Loading…

Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service

Differential association of risk factors associated with relapse following treatment of first-episode psychosis (FEP) have not been studied adequately, especially for patients treated in specialized early intervention (SEI) services, where some of the usual risk factors may be ameliorated. Consecuti...

Full description

Saved in:
Bibliographic Details
Published in:Psychological medicine 2008-11, Vol.38 (11), p.1585-1593
Main Authors: Malla, A., Norman, R., Bechard-Evans, L., Schmitz, N., Manchanda, R., Cassidy, C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c469t-1b26ca5a5d29c6b6d04778d5ede674dfbfbc3c4a09b4a571a8c5f1a97aebcf0c3
cites cdi_FETCH-LOGICAL-c469t-1b26ca5a5d29c6b6d04778d5ede674dfbfbc3c4a09b4a571a8c5f1a97aebcf0c3
container_end_page 1593
container_issue 11
container_start_page 1585
container_title Psychological medicine
container_volume 38
creator Malla, A.
Norman, R.
Bechard-Evans, L.
Schmitz, N.
Manchanda, R.
Cassidy, C.
description Differential association of risk factors associated with relapse following treatment of first-episode psychosis (FEP) have not been studied adequately, especially for patients treated in specialized early intervention (SEI) services, where some of the usual risk factors may be ameliorated. Consecutive FEP patients treated in an SEI service over a 4-year period were evaluated for relapse during a 2-year follow-up. Relapse was based on ratings on the Scale for Assessment of Positive Symptoms (SAPS) and weekly ratings based on the Life Chart Schedule (LCS). Predictor variables included gender, duration of untreated psychosis (DUP), total duration of untreated illness (DUI), age of onset, pre-morbid adjustment, co-morbid diagnosis of substance abuse during follow-up and adherence to medication. Univariate analyses were followed by logistic regression for rate of relapse and survival analysis with the Cox proportional-hazards regression model for time to relapse as the dependent variables. Of the 189 eligible patients, 145 achieved remission of positive symptoms. A high rate of medication adherence (85%) and relatively low relapse rates (29.7%) were observed over the 2-year follow-up. A higher relapse rate was associated with a co-morbid diagnosis of substance abuse assessed during the follow-up period [odds ratio (OR) 2.84, 95% confidence interval (CI) 1.24-6.51]. The length of time to relapse was not associated with any single predictor. Specialized treatment of substance abuse may be necessary to further reduce risk of relapse even after improving adherence to medication.
doi_str_mv 10.1017/S0033291707002656
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_57258626</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0033291707002656</cupid><sourcerecordid>57258626</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-1b26ca5a5d29c6b6d04778d5ede674dfbfbc3c4a09b4a571a8c5f1a97aebcf0c3</originalsourceid><addsrcrecordid>eNp1kVtrFTEUhYMo9lj9Ab5IEPRtNMnkMnmUYqu0IGJ9DpnMTk3NmYzJjPYUf7wZzqEFxadc9rfW3puF0HNK3lBC1dsvhLQt01QRRQiTQj5AG8qlbjqtuodos5abtX6EnpRyTQhtKWeP0RHtGBFa6g36fWrdnHLBYfRxgdGF8QpniHYqgIclr0-LWbMDm7FPMaZfzTLh5LEPucwNTKGkAfBUdu5bKmE1qoIygQs2hlsYcFXGXf2eIf-EcQ5pxKVeg4On6JG3scCzw3mMvp6-vzz50Fx8Ovt48u6icXWZuaE9k84KKwamnezlQLhS3SBgAKn44Hvfu9ZxS3TPrVDUdk54arWy0DtPXHuMXu99p5x-LFBmsw3FQYx2hLQUIxQTnWSygi__Aq_Tksc6m2GEcy0I1xWie8jlVEoGb6YctjbvDCVmzcX8k0vVvDgYL_0WhnvFIYgKvDoAtjgbfbY1inLHMaJkx3RXuWbPhTLDzV3d5u9GqlYJI88-m_PaWih-bi4r3x6Gtds-h-EK7lf6_7h_AHu-tcc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204495049</pqid></control><display><type>article</type><title>Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Cambridge Journals Online</source><source>Social Science Premium Collection</source><source>Sociology Collection</source><creator>Malla, A. ; Norman, R. ; Bechard-Evans, L. ; Schmitz, N. ; Manchanda, R. ; Cassidy, C.</creator><creatorcontrib>Malla, A. ; Norman, R. ; Bechard-Evans, L. ; Schmitz, N. ; Manchanda, R. ; Cassidy, C.</creatorcontrib><description>Differential association of risk factors associated with relapse following treatment of first-episode psychosis (FEP) have not been studied adequately, especially for patients treated in specialized early intervention (SEI) services, where some of the usual risk factors may be ameliorated. Consecutive FEP patients treated in an SEI service over a 4-year period were evaluated for relapse during a 2-year follow-up. Relapse was based on ratings on the Scale for Assessment of Positive Symptoms (SAPS) and weekly ratings based on the Life Chart Schedule (LCS). Predictor variables included gender, duration of untreated psychosis (DUP), total duration of untreated illness (DUI), age of onset, pre-morbid adjustment, co-morbid diagnosis of substance abuse during follow-up and adherence to medication. Univariate analyses were followed by logistic regression for rate of relapse and survival analysis with the Cox proportional-hazards regression model for time to relapse as the dependent variables. Of the 189 eligible patients, 145 achieved remission of positive symptoms. A high rate of medication adherence (85%) and relatively low relapse rates (29.7%) were observed over the 2-year follow-up. A higher relapse rate was associated with a co-morbid diagnosis of substance abuse assessed during the follow-up period [odds ratio (OR) 2.84, 95% confidence interval (CI) 1.24-6.51]. The length of time to relapse was not associated with any single predictor. Specialized treatment of substance abuse may be necessary to further reduce risk of relapse even after improving adherence to medication.</description><identifier>ISSN: 0033-2917</identifier><identifier>EISSN: 1469-8978</identifier><identifier>DOI: 10.1017/S0033291707002656</identifier><identifier>PMID: 18205969</identifier><identifier>CODEN: PSMDCO</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Adjustment ; Adolescent ; Adult ; Age Factors ; Antipsychotic Agents - therapeutic use ; Antipsychotics ; Biological and medical sciences ; Case Management ; Cognition &amp; reasoning ; Community treatment. Ambulatory treatment. Home care ; Comorbidity ; Drug abuse ; Early intervention ; Female ; First time ; First-episode psychosis ; Follow-Up Studies ; Hallucinations ; Humans ; Male ; Medical sciences ; Middle Aged ; Patient Compliance - psychology ; Patient Compliance - statistics &amp; numerical data ; Patients ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Psychosis ; Psychotic Disorders - diagnosis ; Psychotic Disorders - epidemiology ; Psychotic Disorders - rehabilitation ; Psychotropic drugs ; Recurrence ; Relapse ; Remission (Medicine) ; Risk Factors ; Sex Factors ; Social Adjustment ; substance abuse ; Substance-Related Disorders - diagnosis ; Substance-Related Disorders - epidemiology ; Substance-Related Disorders - rehabilitation ; Treatments ; Young Adult</subject><ispartof>Psychological medicine, 2008-11, Vol.38 (11), p.1585-1593</ispartof><rights>Copyright © 2008 Cambridge University Press</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-1b26ca5a5d29c6b6d04778d5ede674dfbfbc3c4a09b4a571a8c5f1a97aebcf0c3</citedby><cites>FETCH-LOGICAL-c469t-1b26ca5a5d29c6b6d04778d5ede674dfbfbc3c4a09b4a571a8c5f1a97aebcf0c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/204495049/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/204495049?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,12846,21394,21395,27924,27925,30999,31000,33611,33612,34530,34531,43733,44115,72832,74093,74511</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20768298$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18205969$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Malla, A.</creatorcontrib><creatorcontrib>Norman, R.</creatorcontrib><creatorcontrib>Bechard-Evans, L.</creatorcontrib><creatorcontrib>Schmitz, N.</creatorcontrib><creatorcontrib>Manchanda, R.</creatorcontrib><creatorcontrib>Cassidy, C.</creatorcontrib><title>Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service</title><title>Psychological medicine</title><addtitle>Psychol. Med</addtitle><description>Differential association of risk factors associated with relapse following treatment of first-episode psychosis (FEP) have not been studied adequately, especially for patients treated in specialized early intervention (SEI) services, where some of the usual risk factors may be ameliorated. Consecutive FEP patients treated in an SEI service over a 4-year period were evaluated for relapse during a 2-year follow-up. Relapse was based on ratings on the Scale for Assessment of Positive Symptoms (SAPS) and weekly ratings based on the Life Chart Schedule (LCS). Predictor variables included gender, duration of untreated psychosis (DUP), total duration of untreated illness (DUI), age of onset, pre-morbid adjustment, co-morbid diagnosis of substance abuse during follow-up and adherence to medication. Univariate analyses were followed by logistic regression for rate of relapse and survival analysis with the Cox proportional-hazards regression model for time to relapse as the dependent variables. Of the 189 eligible patients, 145 achieved remission of positive symptoms. A high rate of medication adherence (85%) and relatively low relapse rates (29.7%) were observed over the 2-year follow-up. A higher relapse rate was associated with a co-morbid diagnosis of substance abuse assessed during the follow-up period [odds ratio (OR) 2.84, 95% confidence interval (CI) 1.24-6.51]. The length of time to relapse was not associated with any single predictor. Specialized treatment of substance abuse may be necessary to further reduce risk of relapse even after improving adherence to medication.</description><subject>Adjustment</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Antipsychotics</subject><subject>Biological and medical sciences</subject><subject>Case Management</subject><subject>Cognition &amp; reasoning</subject><subject>Community treatment. Ambulatory treatment. Home care</subject><subject>Comorbidity</subject><subject>Drug abuse</subject><subject>Early intervention</subject><subject>Female</subject><subject>First time</subject><subject>First-episode psychosis</subject><subject>Follow-Up Studies</subject><subject>Hallucinations</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Patient Compliance - psychology</subject><subject>Patient Compliance - statistics &amp; numerical data</subject><subject>Patients</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Psychosis</subject><subject>Psychotic Disorders - diagnosis</subject><subject>Psychotic Disorders - epidemiology</subject><subject>Psychotic Disorders - rehabilitation</subject><subject>Psychotropic drugs</subject><subject>Recurrence</subject><subject>Relapse</subject><subject>Remission (Medicine)</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Social Adjustment</subject><subject>substance abuse</subject><subject>Substance-Related Disorders - diagnosis</subject><subject>Substance-Related Disorders - epidemiology</subject><subject>Substance-Related Disorders - rehabilitation</subject><subject>Treatments</subject><subject>Young Adult</subject><issn>0033-2917</issn><issn>1469-8978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><sourceid>ALSLI</sourceid><sourceid>HEHIP</sourceid><sourceid>M2S</sourceid><recordid>eNp1kVtrFTEUhYMo9lj9Ab5IEPRtNMnkMnmUYqu0IGJ9DpnMTk3NmYzJjPYUf7wZzqEFxadc9rfW3puF0HNK3lBC1dsvhLQt01QRRQiTQj5AG8qlbjqtuodos5abtX6EnpRyTQhtKWeP0RHtGBFa6g36fWrdnHLBYfRxgdGF8QpniHYqgIclr0-LWbMDm7FPMaZfzTLh5LEPucwNTKGkAfBUdu5bKmE1qoIygQs2hlsYcFXGXf2eIf-EcQ5pxKVeg4On6JG3scCzw3mMvp6-vzz50Fx8Ovt48u6icXWZuaE9k84KKwamnezlQLhS3SBgAKn44Hvfu9ZxS3TPrVDUdk54arWy0DtPXHuMXu99p5x-LFBmsw3FQYx2hLQUIxQTnWSygi__Aq_Tksc6m2GEcy0I1xWie8jlVEoGb6YctjbvDCVmzcX8k0vVvDgYL_0WhnvFIYgKvDoAtjgbfbY1inLHMaJkx3RXuWbPhTLDzV3d5u9GqlYJI88-m_PaWih-bi4r3x6Gtds-h-EK7lf6_7h_AHu-tcc</recordid><startdate>20081101</startdate><enddate>20081101</enddate><creator>Malla, A.</creator><creator>Norman, R.</creator><creator>Bechard-Evans, L.</creator><creator>Schmitz, N.</creator><creator>Manchanda, R.</creator><creator>Cassidy, C.</creator><general>Cambridge University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20081101</creationdate><title>Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service</title><author>Malla, A. ; Norman, R. ; Bechard-Evans, L. ; Schmitz, N. ; Manchanda, R. ; Cassidy, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-1b26ca5a5d29c6b6d04778d5ede674dfbfbc3c4a09b4a571a8c5f1a97aebcf0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adjustment</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Antipsychotics</topic><topic>Biological and medical sciences</topic><topic>Case Management</topic><topic>Cognition &amp; reasoning</topic><topic>Community treatment. Ambulatory treatment. Home care</topic><topic>Comorbidity</topic><topic>Drug abuse</topic><topic>Early intervention</topic><topic>Female</topic><topic>First time</topic><topic>First-episode psychosis</topic><topic>Follow-Up Studies</topic><topic>Hallucinations</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Patient Compliance - psychology</topic><topic>Patient Compliance - statistics &amp; numerical data</topic><topic>Patients</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Psychosis</topic><topic>Psychotic Disorders - diagnosis</topic><topic>Psychotic Disorders - epidemiology</topic><topic>Psychotic Disorders - rehabilitation</topic><topic>Psychotropic drugs</topic><topic>Recurrence</topic><topic>Relapse</topic><topic>Remission (Medicine)</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Social Adjustment</topic><topic>substance abuse</topic><topic>Substance-Related Disorders - diagnosis</topic><topic>Substance-Related Disorders - epidemiology</topic><topic>Substance-Related Disorders - rehabilitation</topic><topic>Treatments</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Malla, A.</creatorcontrib><creatorcontrib>Norman, R.</creatorcontrib><creatorcontrib>Bechard-Evans, L.</creatorcontrib><creatorcontrib>Schmitz, N.</creatorcontrib><creatorcontrib>Manchanda, R.</creatorcontrib><creatorcontrib>Cassidy, C.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest Research Library</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Psychological medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Malla, A.</au><au>Norman, R.</au><au>Bechard-Evans, L.</au><au>Schmitz, N.</au><au>Manchanda, R.</au><au>Cassidy, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service</atitle><jtitle>Psychological medicine</jtitle><addtitle>Psychol. Med</addtitle><date>2008-11-01</date><risdate>2008</risdate><volume>38</volume><issue>11</issue><spage>1585</spage><epage>1593</epage><pages>1585-1593</pages><issn>0033-2917</issn><eissn>1469-8978</eissn><coden>PSMDCO</coden><abstract>Differential association of risk factors associated with relapse following treatment of first-episode psychosis (FEP) have not been studied adequately, especially for patients treated in specialized early intervention (SEI) services, where some of the usual risk factors may be ameliorated. Consecutive FEP patients treated in an SEI service over a 4-year period were evaluated for relapse during a 2-year follow-up. Relapse was based on ratings on the Scale for Assessment of Positive Symptoms (SAPS) and weekly ratings based on the Life Chart Schedule (LCS). Predictor variables included gender, duration of untreated psychosis (DUP), total duration of untreated illness (DUI), age of onset, pre-morbid adjustment, co-morbid diagnosis of substance abuse during follow-up and adherence to medication. Univariate analyses were followed by logistic regression for rate of relapse and survival analysis with the Cox proportional-hazards regression model for time to relapse as the dependent variables. Of the 189 eligible patients, 145 achieved remission of positive symptoms. A high rate of medication adherence (85%) and relatively low relapse rates (29.7%) were observed over the 2-year follow-up. A higher relapse rate was associated with a co-morbid diagnosis of substance abuse assessed during the follow-up period [odds ratio (OR) 2.84, 95% confidence interval (CI) 1.24-6.51]. The length of time to relapse was not associated with any single predictor. Specialized treatment of substance abuse may be necessary to further reduce risk of relapse even after improving adherence to medication.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>18205969</pmid><doi>10.1017/S0033291707002656</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0033-2917
ispartof Psychological medicine, 2008-11, Vol.38 (11), p.1585-1593
issn 0033-2917
1469-8978
language eng
recordid cdi_proquest_miscellaneous_57258626
source Applied Social Sciences Index & Abstracts (ASSIA); Cambridge Journals Online; Social Science Premium Collection; Sociology Collection
subjects Adjustment
Adolescent
Adult
Age Factors
Antipsychotic Agents - therapeutic use
Antipsychotics
Biological and medical sciences
Case Management
Cognition & reasoning
Community treatment. Ambulatory treatment. Home care
Comorbidity
Drug abuse
Early intervention
Female
First time
First-episode psychosis
Follow-Up Studies
Hallucinations
Humans
Male
Medical sciences
Middle Aged
Patient Compliance - psychology
Patient Compliance - statistics & numerical data
Patients
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychoses
Psychosis
Psychotic Disorders - diagnosis
Psychotic Disorders - epidemiology
Psychotic Disorders - rehabilitation
Psychotropic drugs
Recurrence
Relapse
Remission (Medicine)
Risk Factors
Sex Factors
Social Adjustment
substance abuse
Substance-Related Disorders - diagnosis
Substance-Related Disorders - epidemiology
Substance-Related Disorders - rehabilitation
Treatments
Young Adult
title Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A18%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20influencing%20relapse%20during%20a%202-year%20follow-up%20of%20first-episode%20psychosis%20in%20a%20specialized%20early%20intervention%20service&rft.jtitle=Psychological%20medicine&rft.au=Malla,%20A.&rft.date=2008-11-01&rft.volume=38&rft.issue=11&rft.spage=1585&rft.epage=1593&rft.pages=1585-1593&rft.issn=0033-2917&rft.eissn=1469-8978&rft.coden=PSMDCO&rft_id=info:doi/10.1017/S0033291707002656&rft_dat=%3Cproquest_cross%3E57258626%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c469t-1b26ca5a5d29c6b6d04778d5ede674dfbfbc3c4a09b4a571a8c5f1a97aebcf0c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=204495049&rft_id=info:pmid/18205969&rft_cupid=10_1017_S0033291707002656&rfr_iscdi=true